Tartrate-resistant acid phosphatase as a biomarker of bone turnover in dog;Fosfatase ácida resistente ao tartarato como biomarcador do metabolismo ósseo no cão

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia

Volumn 63, Issue 1, 2011, Pages 40-45

  Sousa, C P ^a,b   Nery, F ^c   Azevedo, J T ^d   Viegas, C A ^a,b   Gomes, M E ^b   Dias, I R ^a,b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c Laboratory of Clinical Pathology of Pioledo SA   (Portugal)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Bone metabolism; Bone resorption; Dog; Osteoclast

Indexed keywords

CANIS FAMILIARIS;

EID: 79955428522     PISSN: 01020935     EISSN: 16784162     Source Type: Journal    
DOI: 10.1590/S0102-09352011000100007     Document Type: Article

References (25)

1. ALLEN, L.C.V.; ALLEN, M.J.; BREUER, G.J. et al. A comparison of two techniques for the determination of serum bone-specific alkaline phosphatase activity in dogs. Res. Vet. Sci., v.68, p.231-235, 2000.
2. ALLEN, M.; HOFFMANN, W.; RICHARDSON, D. et al. Serum markers of bone metabolism in dogs. Am. J. Vet. Res., v.59, p.250-254, 1998.
3. ALLEN, M.J. Biochemical markers of bone metabolism in animals: uses and limitations. Vet. Clin. Pathol., v.32, p.101-113, 2003.
4. CHAO, T.Y.; YU, C.Y.; KU, C.H. et al. Tartrate-resistant acid phopshatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Clin. Cancer Res., v.11, p.544-550, 2005.
5. GARNERO, P.; SORNAY-RENDU, E.; DUBOEUF, F. et al. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the Ofely study. J. Bone Miner. Res., v.14, p.1614-1621, 2002.
6. GERDHEM, P.; IVASKA, K.; ALATALO, S. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J. Bone Miner. Res., v.19, p.386-393, 2004.
7. HALLEN, J. Tartrate-acid phosphatase 5b (TRAP 5b) as a marker of bone resorption. Immunodiagn. Syst., v.3, p.1-10, 2006.
8. HALLEN, J.M.; YLIPAHKALA, H.; ATALATO, S.L. et al. Serum tartrate-acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif. Tissue Int., v.71, p.20-25, 2002.
9. HERRMANN, M.; KLITSCHER, D.; GEORG, T. et al. Different kinetics of bone markers in normal and delayed fracture healing of long bones. Clin. Chem., v.48, p.2263-2266, 2002.
10. JOERRING, S.; JENSEN, L.T.; ANDERSEN, G.R. et al. Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch. Orthop. Trauma Surg., v.111, p.265-267, 1992.
11. KANEKO, J.J.; HARVEY, J.W.; BRUSS, M.L. Clinical biochemistry in domestic animals. San Diego: Academic, 2008. 893p.
12. KOMNENOU, A.; KARAYANNOPOULU, M.; POLIZOPOULOU, Z.S. et al. Correlation of serum alkaline phosphatase activity with the healing process of long bone fractures in dogs. Vet. Clin. Pathol., v.34, p.35-38, 2005.
13. KURDY, N.M.G. Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J. Orthop. Trauma, v.14, p.48-53, 2000.
14. LADLOW, J.F.; HOFFMANN, W.E.; BREUR, G.J. et al. Biological variability in serumand urinary indices of bone formation and resorption in dogs. Calcif. Tissue Int., v.70, p.186-193, 2002.
15. LAURER, H.; HAGENBOURGER, O.; QUAST, S. et al. Sequential changes and pattern of bone-specific alkaline phosphatase after trauma. Eur. J. Trauma, v.26, p.33-38, 2000.
16. LEE, H.B.; ALAM, M.R.; SEOL, J.W. et al. Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in early stages of canine osteoarthritis. Vet. Med., v.53, p.214-220, 2008.
17. LEEMING, D.J.; ALEXANDERSEN, P.; KARSDAL, M.A. et al. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur. J. Clin. Pharmacol., v.62, p.781-792, 2006.
18. NENONEN, A.; CHENG, S.; IVASKA, K. Serum TRAP 5b is a useful marker for monitoring alendronate tratment: comparison with other markers of bone turnover. J. Bone Miner. Res., v.20, p.1804-1812, 2005.
19. PANTEGHINI, M.; PAGANI, F. Biological variation in bone-derived biochemical markers in serum. Scand. J. Clin. Lab. Invest., v.55, p.609-616, 1995.
20. PASKALEV, M.; KRASTEV, S.; FILIPOV, J. Changes in some serum bone markers after experimental fracture and intramedullary osteosynthesis in dogs. Trakia J. Sci., v.3, p.46-50, 1995.
21. PHILIPOV, J.P.; PASCALEV, M.D.; AMINKOV, B.Y. et al. Serum carboxyterminal telopeptide of type I collagen in an experimental model of canine osteomyelitis. Calcif. Tissue Int., v.57, p.152-154, 1995.
22. SEEBECK, P.; BAIL, H.J.; EXNER, C. et al. Do serological tissue markers represent callus formation during fracture healing? Bone, v.37, p.669-677, 2005.
23. SEIBEL, M. The use of molecular markers of bone turnover in the management of patients with metastatic bone disease. Clin. Endocrinol., v.68, p.839-849, 2008.
24. SOUTHWOOD, L.L.; FRISBIE, D.D.; KAWCAK, C.E. et al. Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits. Am. J. Vet. Res., v.64, p.727-35, 2003.
25. THEYSE, L.; MOL, J.A.; VOORHOUT, G. et al. The efficacy of the bone markers osteocalcin and the carboxyterminal cross-linked telopeptide of type-I collagen in evaluating osteogenesis in a canine crural lengthening model. Vet. J., v.171, p.525-531, 2005.